Close menu



About Promise Proteomics

Experience and Innovation
for targeted protein quantification

Promise Advanced Proteomics was created in 2010 and is now a full 
subsidiary of the Aguettant group. Promise Proteomics is based in Grenoble, France

Promise Proteomics offer

Promise Proteomics ethos is to develop innovative mass spectrometry-based technologies to address protein absolute quantification in biological samples.

Promise protects its innovative developments by national and international patents and brands.

These rights secure the exclusive marketing of our unique products and thus contribute to the economic success of our company.

  • Stable isotope labelled and unlabelled protein products

Our stable isotope labelled, and unlabelled full-length recombinant protein products are used by customers involved in these main application areas:

  • Biomarkers evaluation and validation
  • Pharmacokinetics studies of biotherapeutics
  • Development of Certified Reference Materials
  • Quantitation of therapeutic monoclonal antibodies in clinical research studies

Our commitments

  • High-quality products developed for and approved by our clients worldwide
  • High-level expertise based on strong R&D
  • Custom solutions tailored to client requirement
  • Cutting-edge technologies including state of the art LC-MS instrumentation